Medical equipment report offering, “Belgium Patient Monitoring Market Outlook to 2016” provides key market data on the Belgium patient monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Multiparameter Patient Monitoring, Remote Patient Monitoring, Patient Monitoring Leads and Electrodes, Non-invasive Blood Pressure Monitors, Neonatal Monitors, Fetal Monitors and Micro-electromechanical Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Patient Monitoring, Patient Monitoring Leads and Electrodes, Non-invasive Blood Pressure Monitors, Neonatal Monitors, Fetal Monitors and Micro-electromechanical Systems.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the Belgium patient monitoring market.
• Key players covered include Philips Healthcare, GE Healthcare, Draegerwerk AG & Co. KGaA, OMRON HEALTHCARE Co., Ltd., Nihon Kohden Corporation, Mindray Medical International Limited and Medtronic, Inc.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Belgium patient monitoring competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

Philips Healthcare
GE Healthcare
Draegerwerk AG & Co. KGaA
OMRON HEALTHCARE Co., Ltd.
HARTMANN GROUP
A&D Medical / LifeSource
3M Health Care
Welch Allyn Inc.
The Dixion Company
Terumo Corporation
St. Jude Medical, Inc.
Spacelabs Healthcare, Inc.
Siemens Healthcare
Schiller AG
Rossmax International Ltd.
OSI Systems, Inc.
Nihon Kohden Corporation
Mindray Medical International Limited
Microlife Corporation
Mennen Medical Ltd.
Medtronic, Inc.
Larsen & Toubro Medical Equipment & Systems
GE Sensing & Inspection Technologies
Fukuda Denshi Co., Ltd.
Edwards Lifesciences Corporation
Edan Instruments, Inc.
Criticare Systems, Inc.
Covidien plc
CONMED Corporation
LifeWatch AG
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
Bionet Co.,Ltd.
AViTA Corporation
Ambu A/S
Patient Monitoring Market Pipeline Products

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3143/Belgium-Patient-Monitoring-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides key market data on the South Africa diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the South Africa diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the South Africa diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Bayer HealthCare AG
LifeScan, Inc.
Sanofi-Aventis
Novo Nordisk A/S
Eli Lilly and Company
B. Braun Melsungen AG
Medtronic, Inc.
Abbott Laboratories
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3198/South-Africa-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Mexico Diabetes Care Devices Market Outlook to 2016” provides key market data on the Mexico diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Mexico diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Mexico diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Bayer HealthCare AG
Abbott Laboratories
B. Braun Melsungen AG
Novo Nordisk A/S
Sanofi-Aventis
Medtronic, Inc.
Eli Lilly and Company
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3197/Mexico-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key market data on the Belgium diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Belgium diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Belgium diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Sanofi-Aventis
LifeScan, Inc.
Bayer HealthCare AG
Eli Lilly and Company
Medtronic, Inc.
Novo Nordisk A/S
B. Braun Melsungen AG
Abbott Laboratories
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3196/Belgium-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Netherlands Diabetes Care Devices Market Outlook to 2016” provides key market data on the Netherlands diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Netherlands diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Netherlands diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Sanofi-Aventis
Bayer HealthCare AG
Abbott Laboratories
LifeScan, Inc.
Eli Lilly and Company
Medtronic, Inc.
Novo Nordisk A/S
Becton, Dickinson and Company
Smiths Medical
B. Braun Melsungen AG
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation
Diabetes Management International BV

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3195/Netherlands-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Brazil Diabetes Care Devices Market Outlook to 2016” provides key market data on the Brazil diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Brazil diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Brazil diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Novo Nordisk A/S
Sanofi-Aventis
Medtronic, Inc.
Bayer HealthCare AG
Becton, Dickinson and Company
B. Braun Melsungen AG
Abbott Laboratories
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation
Eli Lilly and Company

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3194/Brazil-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key market data on the Australia diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Australia diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Australia diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

Novo Nordisk A/S
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Sanofi-Aventis
Medtronic, Inc.
Eli Lilly and Company
Bayer HealthCare AG
B. Braun Melsungen AG
Abbott Laboratories
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation
AiMedics Pty Ltd
Roche Diagnostics Australia Pty. Ltd.
National Diagnostics Products Pty. Limited

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3193/Australia-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Italy Diabetes Care Devices Market Outlook to 2016” provides key market data on the Italy diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Italy diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Italy diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Bayer HealthCare AG
LifeScan, Inc.
Sanofi-Aventis
B. Braun Melsungen AG
Abbott Laboratories
Novo Nordisk A/S
Smiths Medical
Becton, Dickinson and Company
Medtronic, Inc.
Terumo Corporation
Eli Lilly and Company
ARKRAY, Inc.
Animas Corporation
A. Menarini Diagnostics S.r.l.

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3192/Italy-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “France Diabetes Care Devices Market Outlook to 2016” provides key market data on the France diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the France diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the France diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Abbott Laboratories
Bayer HealthCare AG
Medtronic, Inc.
Novo Nordisk A/S
Sanofi-Aventis
B. Braun Melsungen AG
Eli Lilly and Company
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3191/France-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Medical equipment offering, “Germany Diabetes Care Devices Market Outlook to 2016” provides key market data on the Germany diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Germany diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Germany diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Bayer HealthCare AG
LifeScan, Inc.
Sanofi-Aventis
B. Braun Melsungen AG
Abbott Laboratories
Medtronic, Inc.
Eli Lilly and Company
Novo Nordisk A/S
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation
EKF-diagnostic GmbH

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3190/Germany-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-